Systemic RNA interference (RNAi) therapeutics for the treatment of HIV-1

Saved in:
Bibliographic Details
Other Authors: Rossi, John (Speaker)
Format: Electronic Video
Language:English
Published: London : Henry Stewart Talks, 2014.
Series:Henry Stewart talks. Biomedical & life sciences collection. Antivirals.
Subjects:
Online Access:https://hstalks.com/bs/2659/
Series
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000ngm a2200000 a 4500
001 HST3250
003 UkLoHST
006 m c
007 cr|cna|||a||||
007 vz|czazum
008 140422s2014 enk|||||||||||s|||v|eng d
028 5 0 |a 3250  |b Henry Stewart Talks 
035 |a (UkLoHST)2659 
040 |a UkLoHST  |b eng  |c UkLoHST 
100 1 |a Rossi, John,  |u (Beckman Research Institute of the City of Hope, USA)  |4 spk  |9 104513 
245 1 0 |a Systemic RNA interference (RNAi) therapeutics for the treatment of HIV-1  |h [electronic resource] /  |c John Rossi. 
260 |a London :  |b Henry Stewart Talks,  |c 2014. 
300 |a 1 online resource (1 streaming video file (38 min.) :  |b color, sound). 
490 1 |a Antivirals : latest developments and future progress,  |x 2056-452X 
500 |a Animated audio-visual presentation with synchronized narration. 
500 |a Title from title frames. 
505 0 |a Contents: Systemic RNA interference (RNAi): Therapeutics for the treatment of HIV-1 -- HIV life cycle -- Typical Course of HIV infection -- Why do we need new HIV drugs? -- Major goals of anti-HIV therapies -- Combinatorial RNA based therapy for HIV -- Applying RNAi for the treatment of human diseases -- treat HIV infection by systemic delivery of small RNAs -- Aptamers -- Chimeric-siRNA aptamer uptake into gp120 expressing cells -- Aptamer-targeted RNA interference for HIV-1 therapy -- Aptamer and aptamer chimera mediated inhibition of HIV-1 -- Small animal model for studying anti-HIV RNAi based therapies -- Both aptamer and aptamer chimera inhibit HIV infection -Aptamer and chimeric aptamer-siRNA prevent CD4+ cell decline -- Aptamer and dsiRNAS effect on viral load -- Flexible PAMAM dendrimers with a triethanolamine core -- Dendrimers plus siRNAs form nanoparticles, protect siRNA from degradation and deliver siRNAs to T-lymphocytes -- G5 dendrimer delivered siRNAs down regulate target mRNAs in vitro -- Multiplex siRNAs for HIV-1 treatment -- In vivo analyses of G5 dendrimer delivered siRNAs -- Reductions in HIV loads following dendrimer siRNA injections -- Dendrimer-siRNA complexes protect HIV infected RAG-hu mice from CD4 T cell loss -- Bio distribution of G5 dendrimer siRNAs. 
506 |a Access restricted to subscribers. 
538 |a Mode of access: World Wide Web. 
650 0 |a Antiviral agents.  |9 104514 
650 0 |a Gene therapy.  |9 104515 
650 0 |a HIV infections  |x Treatment.  |9 104516 
650 0 |a Small interfering RNA  |x Therapeutic use.  |9 104517 
650 2 |a Acquired Immunodeficiency Syndrome  |x drug therapy.  |9 104518 
650 2 |a Anti-HIV Agents  |x therapeutic use.  |9 104519 
650 2 |a Genetic Therapy.  |9 104520 
650 2 |a HIV Infections  |x drug therapy.  |9 104521 
650 2 |a HIV-1  |x drug effects.  |9 104522 
650 2 |a Molecular Targeted Therapy.  |9 104523 
650 2 |a RNA Interference.  |9 104524 
650 2 |a RNA, Small Interfering  |x therapeutic use.  |9 104525 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.  |p Antivirals.  |9 104526 
856 4 0 |u https://hstalks.com/bs/2659/ 
856 4 2 |u https://hstalks.com/bs/p/613/  |3 Series 
999 |c 215130  |d 215129